敲除EZH2抑制人宫颈癌细胞系迁移和侵袭

doi:10.16352/j.issn.1001-6325.2022.03.004

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (3): 395-400.doi: 10.16352/j.issn.1001-6325.2022.03.004

敲除EZH2抑制人宫颈癌细胞系迁移和侵袭

陈茜¹, 刘宪¹, 崔南¹, 翟阳^2*

1.西安交通大学第一附属医院生殖医学科,陕西西安 710061;
2.陕西省肿瘤医院肿瘤内科, 陕西西安 710061

收稿日期:2021-03-30 修回日期:2021-08-06 出版日期:2022-03-05 发布日期:2022-03-04
通讯作者: ^* zhaiyang2020@126.com
基金资助:
国家自然科学基金(81672910)

Knockout of EZH2 inhibits migration and invasion of human cervical cancer cell lines

CHEN Qian¹, LIU Xian¹, CUI Nan¹, ZHAI Yang^2*

1. Department of Reproductive Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061;
2. Department of Oncology, Tumor Hospital of Shaanxi Province, Xi'an 710061, China

Received:2021-03-30 Revised:2021-08-06 Online:2022-03-05 Published:2022-03-04
Contact: ^* zhaiyang2020@126.com

摘要/Abstract

摘要： 目的研究zeste基因同源蛋白2(EZH2)对人宫颈癌细胞系迁移和侵袭的影响,并初步探讨其作用机制。方法利用CRISPR/Cas9敲除人宫颈癌HeLa和人子宫颈鳞癌SiHa细胞系中EZH2的表达。划痕实验检测细胞迁移;Transwell小室法检测细胞体外迁移和侵袭;实时荧光定量PCR 检测STAT3 mRNA 水平;Western blot 检测STAT3、p-STAT3蛋白表达。结果 CRISPR/Cas9能够敲除EZH2表达;敲除EZH2组中,HeLa和SiHa细胞的划痕愈合率24 h与48 h和Transwell小室迁移和侵袭穿膜细胞数目均低于对照组(P＜0.05)。与对照组相比,敲除EZH2组的p-STAT3 蛋白水平明显降低(P＜0.05)。结论 EZH2在宫颈癌中发挥促进宫颈癌细胞迁移和侵袭的作用,可能与靶向调控STAT3通路有关,具有作为宫颈癌治疗新靶点的潜能。

关键词: 宫颈癌, EZH2, 迁移和侵袭, STAT3信号通路

Abstract: Objective To explore the effect of EZH2 on the migration and invasion of human cervical cancer cell lines and its mechanism. Methods CRISPR/Cas9 was used to knockout EZH2 expression in HeLa and SiHa cell lines. The migration was detected by scratch test, and the migration and invasion in vitro was detected by Transwell migration and invasion test. The STAT3 mRNA level was detected by real-time fluorescence quantitative PCR, and the expression of STAT3 and p-STAT3 proteins was detected by Western blot. Results CRISPR/Cas9 could knockout EZH2 expression. The wound healing rate of HeLa and SiHa cells in EZH2 knockout group at 24 h and 48 h, and the counting of transmembrane cell migration and invasion in Transwell chamber were lower than those in control group(P＜0.05). Compared with the control group, the protein level of p-STAT3 in EZH2 knockout group was significantly decreased (P＜0.05). Conclusions EZH2 plays an important role in promoting the migration and invasion of cervical cancer cells, which may be related to the targeted regulation of STAT3 pathway, and is a potential target in the treatment of cervical cancer.

Key words: cervical cancer, EZH2, migration and invasion, STAT3 signaling pathway

中图分类号:

R737.33

陈茜, 刘宪, 崔南, 翟阳. 敲除EZH2抑制人宫颈癌细胞系迁移和侵袭[J]. 基础医学与临床, 2022, 42(3): 395-400.

CHEN Qian, LIU Xian, CUI Nan, ZHAI Yang. Knockout of EZH2 inhibits migration and invasion of human cervical cancer cell lines[J]. Basic & Clinical Medicine, 2022, 42(3): 395-400.

参考文献

[1]Siegel RL,Miller KD,Jemal A.Cancer statistics, 2018[J].CA Cancer J Clin,2018,68:7-30.
[2]Venneti S,Garimella MT,Sullivan LM,et al.Evaluation of Histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas[J].Brain Pathol,2013,23:558-564.
[3]Italiano A.Role of the EZH2 histone methyltransferase as a therapeutic target in cancer[J].Pharmacol Ther,2016,165:26-31.
[4]Wen Y,Jing C,Hou Y,et al. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target[J].Oncotarget,2017,8:37974-37990.
[5]Chen Q,Zheng PS,Yang WT.EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma[J]. Oncotarget,2016,7:36115-36129.
[6]Chen YH,Yang SF,Yang CK,et al. Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells[J].Mol Med Rep,2021.doi:10.3892/mmr.2020.11725.
[7]Zhou L,Mudianto T, Ma X, et al. Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti-PD-1 resistance in head and neck cancer[J].Clin Cancer Res,2020,26: 290-300.
[8]Lachat C,D Bruyère,Etcheverry A,et al. EZH2 and KDM6B expressions are associated with specific epigenetic signatures during EMT in non small cell lung carcinomas[J].Cancers,2020,12:3649. doi: 10.3390/cancers12123649.
[9]Chien YC,Liu LC,Ye HY,et al. EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway.[J].Am J Cancer Res,2018,8:422-434.
[10]Xu SG,Yu JJ,Shi Q,et al. Conditionally replicative adenovirus carrying shRNA targeting EZH2 inhibits prostate cancer growth and invasion[J]. Oncol Rep,2019,42:273-282.
[11]Chen XQ,Lv XY,Liu SJ. Baitouweng decoction alleviates dextran sulfate sodium-induced ulcerative colitis by regulating intestinal microbiota and the IL-6/STAT3 signaling pathway[J].J Ethnopharmacol,2021,265:113357.doi: 10.1016/j.jep.2020.113357.
[12]张锦锦,唐慧.JAK/STAT3信号通路调控肿瘤及其相关生物功能的研究进展[J].基础医学与临床,2017,37:1456-1460.
[13]宋茜,黄雪,覃蒙斌,等.STAT3通路参与白细胞介素-22促进人结肠癌细胞系HT29紧密连接蛋白的表达[J].基础医学与临床,2021,6: 792-798.
[14]Chen Z, Du Y, Liu X,et al. EZH2 inhibition suppresses bladder cancer cell growth and metastasis via the JAK2/STAT3 signaling pathway[J]. Oncol Lett,2019, 18:907-915.
[15]Kim E, Kim M, Woo DH,et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells[J]. Cancer Cell,2013, 23:839-852.

敲除EZH2抑制人宫颈癌细胞系迁移和侵袭

Knockout of EZH2 inhibits migration and invasion of human cervical cancer cell lines

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨铠菲, 朱静格, 张洋洋, 赵俊果, 高雨悦, 胡焕焕, 姬国杰. 索拉菲尼诱导的细胞凋亡和自噬对HeLa细胞耐药性的影响[J]. 基础医学与临床, 2024, 44(4): 467-473.
[2]	王春燕, 王萍, 宋龙飞, 刘永全, 满君. LncRNA FEZF1-AS1通过调控EZH2对肺间质细胞增殖、迁移及侵袭的作用[J]. 基础医学与临床, 2024, 44(1): 43-50.
[3]	张禹鑫, 朱紫薇, 张燕, 胡玉红. 山萘酚调控VPS9D1-AS1/miR-377-3p对人宫颈癌细胞系SiHa增殖和凋亡的影响[J]. 基础医学与临床, 2023, 43(7): 1069-1078.
[4]	秦玉春, 邝向东, 蔡林再, 谢景臣, 陈山. 双氢青蒿素减轻慢性阻塞性肺疾病(COPD)模型大鼠肺损伤[J]. 基础医学与临床, 2023, 43(3): 427-432.
[5]	高朋, 徐丹丹, 张斌, 刘训涛, 舒丽莎. 氯喹对人宫颈癌细胞系HeLa增殖、凋亡及自噬的影响[J]. 基础医学与临床, 2023, 43(10): 1512-1517.
[6]	阮锋, 李贺伟, 龚艳琳, 刘佳丽, 刘平. 过表达miR-217调控EZH2促进骨质疏松模型小鼠BM-MSCs成骨分化[J]. 基础医学与临床, 2022, 42(9): 1406-1413.
[7]	哈提米汗·买买提, 姑丽克孜·买买提热夏提, 李俞霆, 周常慧, 李榕. CBX7蛋白在宫颈癌中的表达及其临床意义[J]. 基础医学与临床, 2022, 42(5): 721-725.
[8]	牛世伟, 苏韫, 龚红霞, 李婷婷, 曾元丁, 张晗, 聂蓬. 胃癌患者血清IL-1的升高和癌组织JAK2/STAT3信号通路的激活[J]. 基础医学与临床, 2022, 42(3): 401-405.
[9]	白静, 刘娜, 丁力, 雷丽, 倪瑞, 闫少春, 邵国. 放射治疗后宫颈癌组织内差异表达基因鉴定[J]. 基础医学与临床, 2022, 42(2): 215-220.
[10]	张春利, 齐结华, 宦宇, 吴守乐, 蔡徐山. 干扰ADAM17抑制人宫颈癌细胞系HeLa细胞增殖[J]. 基础医学与临床, 2022, 42(2): 255-259.
[11]	贺春花, 刘冷, 张小柳. miR-99a通过下调RRM2抑制人子宫颈癌HeLa细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2022, 42(11): 1737-1743.
[12]	徐林飞, 张海涛, 刘晟, 蔡海荣, 胡恩平. 白花蛇舌草上调miR-485-5p抑制人膀胱癌细胞系KU-19-19增殖、迁移和侵袭[J]. 基础医学与临床, 2021, 41(6): 842-847.
[13]	向雪芹, 崔权哲, 童玉娜, 詹文斌, 陆静. miR-26a靶向IGF-1抑制子宫肌瘤细胞增殖、迁移和侵袭[J]. 基础医学与临床, 2021, 41(11): 1612-1617.
[14]	苑晓梅, 刘力. 人重组腺病毒rAd-IL-23R的构建与功能鉴定[J]. 基础医学与临床, 2020, 40(5): 662-667.
[15]	孙慧霞, 郭哲, 许静. 沉默HOXB7抑制人宫颈癌细胞系CASKI转移与增强顺铂敏感性[J]. 基础医学与临床, 2020, 40(4): 532-537.